苦杏仁苷

分析标准品,HPLC≥98%

Amygdalin

CAS号：29883-15-6

分子式：C20H27NO11

分子量：457.43

MDL：MFCD00006598

别名：扁桃苷;苦杏仁甙

产品介绍

 扁桃素是从蔷薇果实的果核中分离的植物葡萄糖苷，例如杏，桃，杏仁，樱桃和李子。

熔点：223-226℃

沸点：743.3℃ at 760 mmHg

比旋光度：-38.5 o (C=4, H2O)

外观：斜方柱状结晶

溶解性：DMSO:≥75mg/mL(163.96mM)

H2O:50mg/mL(109.31mM;Needultrasonic)

储存条件：2-8℃

注意：部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

参考文献(58篇)

58. [IF=7.6] Yujie Zhang et al."High-resolution mass spectrometry-based suspect and nontarget screening of natural toxins in foodstuffs and risk assessment of dietary exposure."ENVIRONMENTAL POLLUTION.2024 Nov;:125338

57. [IF=1.5] Ji Wanli et al."Revealing the Active Components and Therapeutic Targets of Sanao Decoction against Chronic Obstructive Pulmonary Disease Using Quantitative Analysis of Multi-Components by Single Marker and Network Pharmacology."JOURNAL OF CHROMATOGRAPHIC

56. [IF=4.8] Xiao Qiang et al."Flavonoids from Cerasus humilis seed coat alleviate constipation in mice: Role of AQP3/4 and c-Kit/SCF signaling pathways."Food Bioscience.2025 Jun;68:106643

55. [IF=5.3] Jiawei Bao et al."A novel efficient method for the simultaneous recycle of amygdalin and oil from bitter apricot kernels: Ultrasonication based on natural deep eutectic solvent."JOURNAL OF MOLECULAR LIQUIDS.2025 Jul;429:127592

54. [IF=5.3] Li Teng et al."Metabolomics integrated with network pharmacology of blood-entry constituents reveals the bioactive component of Xuefu Zhuyu decoction and its angiogenic effects in treating traumatic brain injury."Chinese Medicine.2024 Dec;19(1):1-16

53. [IF=6] Luyu Shan et al."Metabolism and release of characteristic components and profiles of enzymatic activities during fermentation of Massa Medicata Fermentata."LWT-FOOD SCIENCE AND TECHNOLOGY.2024 Oct;209:116793

52. [IF=5.3] Gao Jiaming et al."Buyang Huanwu decoction ameliorates myocardial injury and attenuates platelet activation by regulating the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway."Chinese Medicine.2024 Dec;19(1):1-17

51. [IF=5] Luyao Liu et al."Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome."mSystems.

50. [IF=4.3] Hujun Du et al."Exploring the Underlying Mechanisms of Qingxing Granules Treating H1N1 Influenza Based on Network Pharmacology and Experimental Validation."Pharmaceuticals.2024 Jun;17(6):731

49. [IF=5.4] Yang Wang et al."Buyang huanwu decoction promotes remyelination via miR-760-3p/GPR17 axis after intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY".2024 Jun;328:118126

48. [IF=6] Dianwen Xu et al."Amygdalin Alleviates DSS-Induced Colitis by Restricting Cell Death and Inflammatory Response, Maintaining the Intestinal Barrier, and Modulating Intestinal Flora."Cells".2024 Jan;13(5):444

47. [IF=6] Rui Wang et al."Network Pharmacology-Based Approach reveals that Fructus mume exerts Therapeutic Effects against Ulcerative Colitis via the AGE/RAGE Signaling Pathway."Arabian Journal of Chemistry.2023 Dec;:105534

46. [IF=5.4] Menghan Cheng et al."A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117123

45. [IF=5.4] Bo-Han Wang et al."Qufeng Xuanbi Formula inhibited benzo[a]pyrene-induced aggravated asthma airway mucus secretion by AhR/ROS/ERK pathway."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117203

44. [IF=5.4] Keyan Jiao et al."Glycosides of Buyang Huanwu decoction inhibits inflammation associated with cerebral ischemia-reperfusion via the PINK1/Parkin mitophagy pathway."JOURNAL OF ETHNOPHARMACOLOGY.2024 Jan;:117766

43. [IF=4.9] Zhang Min et al."Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro."Chinese Medicine.2023 Dec;18(1):1-14

42. [IF=5.4] Chang Zhou et al."Neuroprotective effects of Jie-du-huo-xue decoction on microglia pyroptosis after cerebral ischemia and Reperfusion——From the perspective of glial-vascular unit."JOURNAL OF ETHNOPHARMACOLOGY.2023 Aug;:116990

41. [IF=4.4] Mengyang Guo et al."Biotransformation of amygdalin by lactic acid bacteria fermentation."PROCESS BIOCHEMISTRY.2023 Sep;132:221

40. [IF=3.4] Wenmin Pi et al."Discovery, traceability, formation mechanism, metal and organic components analysis of supramolecules from Maxing Shigan decoction."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2023 Sep;234:115532

39. [IF=2.745] Guoqin Zhang et al."Analysis of bitter almonds and processed products based on HPLC-fingerprints and chemometry."CHEMISTRY & BIODIVERSITY.2023 Feb;:

38. [IF=3.195] Yan, Fanchen et al."Glycoside combinations of Buyang Huanwu decoction ameliorate atherosclerosis via STAT3, HIF-1, and VEGF."NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.2023 Jan;:1-17

37. [IF=6.056] Xianan Zhang et al."Effect of 1-methylcyclopropene on flat peach fruit quality based on electronic senses, LC-MS, and HS-SPME-GC-MS during shelf storage."LWT-FOOD SCIENCE AND TECHNOLOGY.2023 Jan;173:114388

36. [IF=2.65] Jing Zhou et al."Buyang Huanwu Decoction: A Traditional Chinese Medicine, Promotes Lactate-Induced Angiogenesis in Experimental Intracerebral Hemorrhage."Evidence-based Complementary and Alternative Medicine.2022 Oct 30;2022:4063315

35. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199

34. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231

33. [IF=6.656] Xinying Fu et al."Glycosides from Buyang Huanwu Decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway."PHYTOMEDICINE.2022 Oct;105:154385

32. [IF=1.618] Zhang Guoqin et al."Study on the Correlation Between the Appearance Traits and Intrinsic Chemical Quality of Bitter Almonds Based on Fingerprint-Chemometrics."J Chromatogr Sci. 2022 Apr;:

31. [IF=2.193] Zhang Haibo et al.Systematic Study on a Quantitative Analysis of Multicomponents by Single Marker (QAMS) Method for Simultaneous Determination of Eight Constituents in Pneumonia Mixture by UPLC-MS/MS.J Anal Methods Chem. 2021;2021:8311588

30. [IF=3] Wan  Haoyu et al."Pharmacokinetics of seven major active components of Mahuang decoction in rat blood and brain by LC–MS/MS coupled to microdialysis sampling."N-S Arch Pharmacol. 2020 Aug;393(8):1559-1571

29. [IF=3.935] Pengcheng Huang et al."Correlation study between the pharmacokinetics of seven main active ingredients of Mahuang decoction and its pharmacodynamics in asthmatic rats."J Pharmaceut Biomed. 2020 May;183:113144

28. [IF=4.225] Wei  Wenyang et al."Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A."Front Pharmacol. 2019 Sep;0:961

27. [IF=1.773] Li-Hua ZHOU et al."Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula."Chin J Nat Medicines. 2018 Apr;16:2

26. [IF=3.205] Dong-Dong Hu et al."Simultaneous determination of ten compounds in rat plasma by UPLC-MS/MS: Application in the pharmacokinetic study of Ma-Zi-Ren-Wan."J Chromatogr B. 2015 Sep;1000:136

25. [IF=3.414] Mengkai Zheng et al."Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model."J Ethnopharmacol. 2015 Apr;164:22

24.  Zheng, Mengkai, et al. "Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model." Journal of ethnopharmacology 164 (2015): 22-29.https:##

23.  Zhou, Li-Hua, et al. "Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula." Chin J Nat Med 16 (2018): 241-25

22.  Zhou, Li-Hua, et al. "Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula." Chin J Nat Med 16 (2018): 241-25

21.  王盼,储全根,轩云,蔡正银.抵当陷胸汤HPLC-MS指纹图谱研究[J].时珍国医国药,2020,31(12):2937-2940.

20.  陈开琼,杨其芳,苟琪,吕燕,刘建利.枸杞枝叶中乳酸菌的分离及其在徒长枝青贮中的应用评价[J].中国农业科技导报,2021,23(02):193-201.

19.  薛梦洁,于卉娟,王璐瑶,柴欣,杨静,王跃飞.血府逐瘀汤提取过程中成分的量变规律研究[J].天津中医药,2021,38(01):109-112.

18.  王诗洋,王枭,徐祖清,刘悦,孔繁利.苦杏仁苷通过抑制氧化应激及炎症反应减轻四氯化碳诱导的大鼠肝纤维化作用[J].现代免疫学,2020,40(06):471-475+481.

17.  刘月波  章小敏  洪冰 等. HPLC-DAD法比较不同剂型麻黄汤及其拆方中有效成分含量[J]. 中国中医药科技  2020(1).

16.  万嘉洋, 田彦芳, 万海同,等. 麻黄汤有效组分配伍在发热大鼠体内的药动学研究[J]. 中国中药杂志, 2019(10).

15.  冯伦元, 何腊平, 李翠芹,等. 贵州传统发酵豆制品中水解银杏黄酮苷的微生物β-葡萄糖苷酶筛选[J]. 微生物学报, 2020(2).

14.  杨爽, 何妍茜, 杨洁,等. 感冒软胶囊质量标准提高的研究[J]. 时珍国医国药, 2013, 24(008):1930-1932.

13.  陈俊怡, 贾天柱. 对苦杏仁燀炒炮制意义的商榷[J]. 亚太传统医药, 2012, 08(006):48-50.

12.  杨丽,李莹,王清娴,孙勇兵,刘湾,李文宏.麻黄-杏仁药对配比与有效成分含量变化规律研究[J].中国当代医药,2017,24(05):4-7+11.

11.  敖波, 侯永春, 赖珍珍,等. 麻黄-杏仁药对成分-效应间变化规律[J]. 中成药, 2018(6).

10.  谢婧, 张志, 李听弦,等. 郁李仁不同炮制品及其水煎液中苦杏仁苷的含量比较[J]. 中国医院药学杂志, 2018(19).

9.  谢朝晖, 李鑫, 李文博,等. 超声波法提取山杏仁中苦杏仁苷的单因素试验研究[J]. 河南城建学院学报, 2012, 21(002):31-38.

8.  孙萌, 叶丽琴, 刘海娇,等. 欧李种质资源评价研究[J]. 中药材, 2017, 40(001):54-57.

7.  卞晓坤, 钱大玮, 段金廒,等. 桃仁与山桃仁化学成分比较研究[J]. 药物分析杂志, 2020, 040(001):123-131.

6.  刘策, 2], 曹清明,等. 杏仁皮的苦杏仁苷含量测定及脱毒工艺探究[J]. 食品研究与开发, 2015(3):59-63.

5.  许照, 肖雄, 黄刚,等. 基于含药肠吸收液的麻黄-杏仁药对物质基础与作用机制分析[J]. 中国实验方剂学杂志, 2018, 024(006):1-6.

4.  陈铭中  钟旭美  刘和平 等. 发酵青梅酒脱苦工艺的优化[J]. 食品研究与开发  2017(11):114-118.

3.  权博文  张慧文  刘广达 等. 十种产地扁桃的HPLC指纹图谱比较[J]. 中华中医药学刊  2018  36(12):2918-2921.

2.  刘瑞琛  刘冬科  李连 等. HPLC-MS/MS同时测定芪龙胶囊中6个有效成分的含量[J]. 药物分析杂志  2020  v.40(05):36-42.

1.  李玲 张波 卢芳国 蔡亮 高强 胡珏 何谷良 吴涛.A型流感病毒对肺巨噬细胞自噬的影响及麻杏石甘汤含药血清的干预作用[J].中国药理学通报 2019 35(06):878-884.

从2011年开始我们致力于在生命科学领域、生物医学实验技术及论文润色服务，协助客户各类实验服务及论文润色十余年，是您值得信赖的科研合作伙伴!

如果您受时间、试验条件等限制而无法完成您的课题研究，欢迎您与我们联系。

实验技术服务：